Literature DB >> 9694231

Levels of tau phosphorylation at different sites in Alzheimer disease brain.

Y Ikura1, T Kudo, T Tanaka, H Tanii, I Grundke-Iqbal, K Iqbal, M Takeda.   

Abstract

The microtubule-associated protein tau is abnormally hyperphosphorylated in Alzheimer's disease (AD) brain. To date, 21 phosphorylated sites of tau have been identified. In the present study the levels of phosphorylation at Ser199/Ser202, Thr231/Ser235, Ser262/Ser356 and Ser396/Ser404 of tau in AD brain homogenate and its 100,000 x g supernatant were determined using radioimmuno-dot-blot assay. In homogenate, Ser199/Ser202 and Ser262/Ser356 were phosphorylated to similar level and were more phosphorylated than Thr231 or Ser396/Ser404. In supernatant, there was no significant difference in phosphorylated tau level among the investigated sites except for Thr231/Ser235 which was least phosphorylated. These results suggest that Ser199/Ser202 and Ser262/Ser356 are major sites of phosphorylation of tau in AD brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694231     DOI: 10.1097/00001756-199807130-00041

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease.

Authors:  W H Yu; P E Fraser
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice.

Authors:  Antonio Currais; Marguerite Prior; David Lo; Corinne Jolivalt; David Schubert; Pamela Maher
Journal:  Aging Cell       Date:  2012-10-01       Impact factor: 9.304

3.  Interaction between eye pigment genes and tau-induced neurodegeneration in Drosophila melanogaster.

Authors:  Surendra S Ambegaokar; George R Jackson
Journal:  Genetics       Date:  2010-06-30       Impact factor: 4.562

4.  PhIP exposure in rodents produces neuropathology potentially relevant to Alzheimer's disease.

Authors:  Tauqeerunnisa Syeda; Rachel M Foguth; Emily Llewellyn; Jason R Cannon
Journal:  Toxicology       Date:  2020-03-10       Impact factor: 4.221

5.  Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.

Authors:  Surendra S Ambegaokar; George R Jackson
Journal:  Hum Mol Genet       Date:  2011-09-23       Impact factor: 6.150

6.  Inhibition of glycogen synthase kinase-3 by BTA-EG4 reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer's disease.

Authors:  Cara L Croft; Ksenia Kurbatskaya; Diane P Hanger; Wendy Noble
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

7.  DHCR24 Knock-Down Induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 Epitopes and Inhibition of Autophagy by Overactivation of GSK3β/mTOR Signaling.

Authors:  Xiaojing Bai; Junfeng Wu; Mengqi Zhang; Yixuan Xu; Lijie Duan; Kai Yao; Jianfeng Zhang; Jimei Bo; Yongfei Zhao; Guoxiong Xu; Hengbing Zu
Journal:  Front Aging Neurosci       Date:  2021-04-21       Impact factor: 5.750

8.  The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology.

Authors:  Liqing Song; Daniel E Oseid; Evan A Wells; Anne Skaja Robinson
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

9.  A comprehensive multiomics approach toward understanding the relationship between aging and dementia.

Authors:  Antonio Currais; Joshua Goldberg; Catherine Farrokhi; Max Chang; Marguerite Prior; Richard Dargusch; Daniel Daugherty; Aaron Armando; Oswald Quehenberger; Pamela Maher; David Schubert
Journal:  Aging (Albany NY)       Date:  2015-11       Impact factor: 5.682

10.  Behavioral Abnormalities in Knockout and Humanized Tau Mice.

Authors:  Rafaella Araujo Gonçalves; Nadeeja Wijesekara; Paul E Fraser; Fernanda G De Felice
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-12       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.